Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20111
20132
20141
20151
20172
20181
20203
20213
20231
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting3
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Ono Pharmaceutical Co., Ltd.3
Amgen2
Boehringer Ingelheim2
Fukushima Medical University2
Wakayama Medical University2
AbbVie1
Astellas Pharma Global Development, Inc.1
GlaxoSmithKline1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms24
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms5
Ovarian Neoplasms5
Esophageal Neoplasms4
Lung Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Triple Negative Breast Neoplasms4
Breast Neoplasms3
Neoplasm Metastasis3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.